Page last updated: 2024-11-08

3-octanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-octanone : A dialkyl ketone that is octane in which the two methylene protons at position 3 have been replaced by an oxo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID246728
CHEMBL ID2269087
CHEBI ID80946
SCHEMBL ID5593
MeSH IDM0068448

Synonyms (66)

Synonym
n-amyl ethyl ketone
3-octanone (natural)
einecs 203-423-0
fema no. 2803
brn 1700021
nsc 60161
un2271
ethyl n-amylketone
3-oxooctane
ethyl amyl ketone [un2271] [flammable liquid]
ai3-36116
hsdb 5371
ethyl pentyl ketone
106-68-3
nsc-60161
eak
ethyl n-pentyl ketone
octan-3-one
n-octanone-3
nsc60161
wln: 5v2
ethyl n-amyl ketone
3-octanone
ethyl amyl ketone
amyl ethyl ketone
3-octanone, >=98%, fg
3-octanone, >=98%
C17145
O0122
A801482
NCGC00248338-01
AKOS005720776
LMFA12000055
tox21_301208
cas-106-68-3
dtxcid1021954
NCGC00255105-01
dtxsid3041954 ,
BBL011431
STL146538
79173b4107 ,
ccris 8808
ethyl amyl ketone [un2271] [flammable liquid]
unii-79173b4107
FT-0616282
octanone, 3-
3-octanone [fhfi]
3-octanone [hsdb]
3-octanone [mi]
SCHEMBL5593
chebi:80946 ,
CHEMBL2269087
1-ethyl hexanal
octane-3-one
octan-6-one
methylheptanone
mfcd00009515
2-heptanone, methyl-
J-001627
3-octanone, analytical standard
3-octanon
fema 2803
3-octanone, natural (us), >=97%, fg
VS-02948
Q18349104
EN300-396111

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"8 × 10(-4) cm s(-1) with all mathematical approaches, indicating high absorption potential and almost complete bioavailability for all tested compounds with hydroxyl-functionalities."( Transport of hop aroma compounds across Caco-2 monolayers.
Buettner, A; Heinlein, A; Metzger, M; Walles, H, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
insect attractantA chemical that attracts insects.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
antifeedantA substance that prevents pests from feeding.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
biomarkerA substance used as an indicator of a biological state.
toxinPoisonous substance produced by a biological organism such as a microbe, animal or plant.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dialkyl ketone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency90.45290.002541.796015,848.9004AID1347395
progesterone receptorHomo sapiens (human)Potency27.63960.000417.946075.1148AID1346784
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.04920.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.00160.001530.607315,848.9004AID1224841; AID1224842; AID1224849
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency35.085719.739145.978464.9432AID1159509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1102925Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 assessed as growth inhibition rate at 6.32 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102894Antimicrobial activity against Vibrio parahaemolyticus ATCC 33844 assessed as growth inhibition rate at 6.32 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102832Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition rate at 6.32 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102956Antimicrobial activity against Bacillus cereus ATCC 11778 assessed as growth inhibition rate at 6.32 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102801Antimicrobial activity against Escherichia coli O157:H7 ATCC 43894 assessed as growth inhibition rate at 6.32 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102863Antimicrobial activity against Listeria monocytogenes ATCC 19111 assessed as growth inhibition rate at 6.32 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.68)18.7374
1990's1 (3.23)18.2507
2000's9 (29.03)29.6817
2010's13 (41.94)24.3611
2020's5 (16.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.72 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.46 (4.65)
Search Engine Demand Index52.41 (26.88)
Search Engine Supply Index1.96 (0.95)

This Compound (39.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]